Ivertol 12 Tablet DT contains Ivermectin 12 mg as its active ingredient, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively and with high affinity to glutamate-gated chloride ion channels in the nerve and muscle cells of invertebrates, leading to increased permeability to chloride ions, hyperpolarization, paralysis, and death of the parasite. This formulation is designed as a dispersible tablet, allowing for ease of administration and improved patient compliance, particularly in populations with swallowing difficulties. Ivertol 12 Tablet DT is indicated for the treatment of strongyloidiasis, onchocerciasis, and other susceptible parasitic infestations caused by nematodes and ectoparasites. It is also employed off-label for certain other parasitic conditions as determined by clinical judgment. The medication should be administered according to the prescribed dosage regimen, typically as a single dose or repeated doses depending on the infection severity and type. Caution is advised in patients with hypersensitivity to ivermectin or any excipients, and it is contraindicated in children weighing less than 15 kg and in pregnant or breastfeeding women unless clearly necessary. Common adverse effects include mild gastrointestinal disturbances, dizziness, and rash. Patients should be monitored for any signs of adverse reactions during therapy.